Clinical and Genetic Examinations of Dilated Cardiomyopathy
1 other identifier
observational
554
1 country
1
Brief Summary
This study is a descriptive study to investigate clinical and genetic features of dilated cardiomyopathy (DCM) patients and their relatives. 109 probands with DCM have been clinically characterized with clinical examinations including ECG and echocardiography, and furthermore they have had next generation sequencing (NGS) of 42 known DCM genes, and 34 candidate genes. The probands were consequtively included in the study and 59 had undergone heart transplantation (HTx) upon inclusion. of these patients underwent heart transplantation. The data from NGS is validated by Sanger sequencing. In this study we will examine the relatives to the 109 index patients by genetic and clinical cascade screening including advanced echocardiography including 3D volume measurements and speckle-tracking (GLS). Genetic investigations of relatives will be performed if a disease-associated mutation is identifed in the proband. Approximately 480 clinical examinations will be performed this way to be able to: 1a. Investigate the frequency of familial types of DCM 1b. To investigate the yield of genetic and clinical cascade screening 2\. To describe genotype phenotype correlations 3\. To investigate if there are subtle changes in the heart in genopositive individuals which do not meet the conventional diagnostic criteria evaluated by advanced echocardiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 23, 2014
CompletedFirst Posted
Study publicly available on registry
May 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedSeptember 25, 2023
September 1, 2023
4.2 years
May 23, 2014
September 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Genetics
Difference in the genetics in the transplanted vs the non-transplanted group
3 years
Secondary Outcomes (1)
Global longitudinal strain
3 years
Eligibility Criteria
Families in Denmark with history of dilated cardiomyopathy. Patients mainly from Funen and Jutland.
You may qualify if:
- Related to one of the index patients
- Available for genetic testing and clinical examinations
You may not qualify if:
- Death
- Not available for genetic testing and clinical examinations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Odense University Hospitalcollaborator
- Aarhus University Hospitalcollaborator
Study Sites (1)
Odense University Hospital
Odense, 5000, Denmark
Biospecimen
DNA for genetic testing
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jens Mogensen, Professor
Odense University Hospital
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Phd. student
Study Record Dates
First Submitted
May 23, 2014
First Posted
May 29, 2014
Study Start
February 1, 2014
Primary Completion
May 1, 2018
Study Completion
June 1, 2018
Last Updated
September 25, 2023
Record last verified: 2023-09